Pharmabiz19h
US FDA approves anti-CD38 therapy, Sarclisa in combo with standard-of-care treatment for adult patients with NDMM who are not eligible for transplant
US FDA approves anti-CD38 therapy, Sarclisa in combo with standard-of-care treatment for adult patients with NDMM who are not eligible for transplant: Paris Tuesday, September 24, ...
Pharmabiz20h
Teva Pharma announces long term efficacy and safety of deutetrabenazine in European patients with debilitating movement disorder tardive dyskinesia
Teva Pharma announces long term efficacy and safety of deutetrabenazine in European patients with debilitating movement disorder tardive dyskinesia: Tel Aviv, Israel Tuesday, Sept ...
Pharmabiz23h
Hyderabad to host landmark awareness programme on NABL accreditation for medical imaging facilities
Hyderabad to host landmark awareness programme on NABL accreditation for medical imaging facilities: Shardul Nautiyal, Mumbai ...
Pharmabiz15h
Innate Pharma gets US FDA clearance to begin phase 1 study of Nectin-4 ADC, IPH4502 to treat solid tumours
Innate Pharma gets US FDA clearance to begin phase 1 study of Nectin-4 ADC, IPH4502 to treat solid tumours: Marseille, France Tuesday, September 24, 2024, 16:00 Hrs [IST] Innate P ...
Pharmabiz17h
Kerala IPA to honour four pharmacy professionals tomorrow as part of World Pharmacist Day celebration
Kerala IPA to honour four pharmacy professionals tomorrow as part of World Pharmacist Day celebration: Our Bureau, Chennai Tuesday, September 24, 2024, 13:30 Hrs [IST] The Kerala ...
Pharmabiz18h
Antengene receives Thailand FDA approval to commercialize Xpovio in Thailand
Antengene receives Thailand FDA approval to commercialize Xpovio in Thailand: Shanghai Tuesday, September 24, 2024, 13:00 Hrs [IST] Antengene Corporation Limited, a leading innova ...
Pharmabiz8h
Nicox, and Glaukos ink exclusive NCX 1728 research and global licensing option agreement
Nicox SA, an international ophthalmology company, announced that it has entered into an exclusive research and license option agreement with Glaukos Corporation for NCX 1728, Nicox’s novel nitric ...
Pharmabiz18h
Arya Vaidya Pharmacy in Coimbatore launches ‘Prachin Vriksha Ayurveda Chikitsa’ to rejuvenate trees
Arya Vaidya Pharmacy in Coimbatore launches ‘Prachin Vriksha Ayurveda Chikitsa’ to rejuvenate trees: Our Bureau, Chennai Tuesday, September 24, 2024, 12:15 Hrs [IST] The Arya ...
Pharmabiz23h
CDSCO declares five samples tested in August as purported to be spurious
CDSCO declares five samples tested in August as purported to be spurious: Gireesh Babu, New Delhi Tuesday, September 24, 2024 ...
Pharmabiz21h
Roche announces WHO included dual-stain cytology testing, CINtec PLUS in its cervical cancer prevention guideline
Roche announces WHO included dual-stain cytology testing, CINtec PLUS in its cervical cancer prevention guideline: Basel Tuesday, September 24, 2024, 10:00 Hrs [IST] Roche announc ...
Pharmabiz20h
API prices to remain weak for India in FY25, says Ind-Ra report
API prices to remain weak for India in FY25, says Ind-Ra report: Our Bureau, New Delhi Tuesday, September 24, 2024, 10:10 Hrs [IST] Active pharmaceutical ingredient (API) prices a ...
Pharmabiz23h
Biotech industry hopes new Vigyan Dhara of Rs. 10,000 crore to strengthen research and woo talent
The biotechnology industry hopes the new Vigyan Dhara initiative of the Union government with a Rs. 10,000 crore outlay will result in better fund utilisation, and improve efficiency with its support ...